Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager What are protein therapeutics / monoclonal antibodies? Protein therapeutics, specifically monoclonal antibodies (mAbs), have emerged as the most marketed biologic drug Continue Reading
Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading
Scientists are some of the smartest people to walk the planet. But even basic chromatography knowledge can evade the most experienced scientist. That is why Phenomenex provides technical assistance nearly Continue Reading
Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager The pharmaceutical industry has a long-standing Continue Reading
Phenomenex and LCGC teamed up to discuss current trends in chiral separation and dig deep into the development and use of chiral stationary phases and separation modes. LCGC conducted a Q Continue Reading
Guest Author: Abraham Becerra Since its discovery, chiral chemistry has played a pivotal role in how scientists examine novel compounds. This unique characteristic describing a molecule’s geometry in three-dimensional space Continue Reading
A social media sensation has finally paid off. The U.S. Food and Drug Administration (FDA) has recently approved the first drug to combat amyotrophic lateral sclerosis, or ALS, in 22 years. Continue Reading
The Humanity in Science Award was created in 2015 to recognize outstanding developments in science that could change human lives for the better. There were many runners-up who did (and do!) amazing things for humanity. Recently, The Analytical Scientist sat down with each of them to catch up, and find out how their ventures have progressed in the last 12 months.